Wiener klinische Wochenschrift Education

, Volume 7, Issue 1, pp 1–20 | Cite as

Asthma bronchiale bei Erwachsenen – Diagnostik & Therapie



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


Einleitung und Definition

  1. Wöhrl S, Radon K, Ring J, et al. GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers. Wien Klin Wochenschr 2009;121: 589–597PubMedCrossRefGoogle Scholar
  2. Anandan C, Nurmatov U, van Schayck OCP, et al. Is the prevalence of asthma declining? Systematic review of epidemiological studies Allergy 2010;65: 152–167Google Scholar
  3. Horak E, Sawyer SM, Roberts M, et al. Impact of disease severity on quality of life in adults with asthma. Wien Klin Wochenschr 2005;117: 462–467PubMedCrossRefGoogle Scholar


  1. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008;372: 1107–1119PubMedCrossRefGoogle Scholar
  2. Lemanske RF Jr, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol 2010;125: S95–102PubMedCrossRefGoogle Scholar
  3. Umetsu DT, Dekruyff RH. Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma. J Allergy Clin Immunol 2010;125: 975–979PubMedCrossRefGoogle Scholar
  4. Barnes PJ. Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clin Exp Allergy 2009;39: 1145–1151PubMedCrossRefGoogle Scholar
  5. Phipps S, Benyahia F, Ou TT, et al. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 2004;31: 626–632PubMedCrossRefGoogle Scholar
  6. Karjalainen EM, Lindqvist A, Laitinen LA, et al. Airway inflammation and basement membrane tenascin in newly diagnosed atopic and non-atopic asthma: Respir Med 2003;97: 1045–1051PubMedCrossRefGoogle Scholar
  7. Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112: 1029–1036PubMedGoogle Scholar
  8. Barnes P. Mechanism in COPD compared with asthma. Breathe 2008;5: 134–144Google Scholar
  9. Groneberg DA, Quarcoo D, Frossard N, et al. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy 2004;59: 1139–1152PubMedCrossRefGoogle Scholar
  10. Grainge CL, Lau LCK, Ward JA, et al. Effect of Bronchoconstriction on Airway Remodeling in Asthma. N Engl J Med 2011;364: 2006–2015PubMedCrossRefGoogle Scholar

Atopic asthma

  1. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003;112: 252–262PubMedCrossRefGoogle Scholar
  2. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372: 1049–1057PubMedCrossRefGoogle Scholar
  3. Shaaban R, Zureik M, Soussan D, et al. Allergic rhinitis and onset of bronchial hyperresponsiveness. A population-based study. Am J Respir Crit Care Med 2007;176: 659–666PubMedCrossRefGoogle Scholar
  4. Ciprandi G, Cirillo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol 2006;118: 1105–1109PubMedCrossRefGoogle Scholar
  5. Cirillo I, Pistorio A, Tosca M, et al. Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity. Allergy 2009;64: 439–444PubMedCrossRefGoogle Scholar
  6. Braunstahl GJ. The unified immune system: respiratory tract-nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol 2005;115: 142–148PubMedCrossRefGoogle Scholar
  7. Braunstahl GJ, Overbeek SE, KleinJan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways molecules. J Allergy Clin Immunol 2001;107: 469–476PubMedCrossRefGoogle Scholar
  8. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 2008;8: 169–182PubMedCrossRefGoogle Scholar
  9. Hawrylowicz C. Asthma and allergy: the early beginnings. Nature Med 2010;16: 274–275PubMedCrossRefGoogle Scholar
  10. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nature Rev Immunol 2008;8: 193–204CrossRefGoogle Scholar
  11. Conrad ML, Ferstl R, Teich R, et al. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J Exp Med. 2009;206: 2869–2877PubMedCrossRefGoogle Scholar

Chemisch toxisch und physikalisch irritativ

  1. Wantke F, Focke M, Hemmer W, et al. Formaldehyde and phenol exposure during an anatomy dissecting course: a possible source for IgE-mediated sensitization? Allergy 1996;51: 837–841PubMedGoogle Scholar
  2. Wantke F, Focke M, Hemmer W, et al. Sensitization against formaldehyde albumin: induction of IgE and IgG against formaldehyde due to different exposure. Allergy 2000;55: 84–87PubMedCrossRefGoogle Scholar
  3. Wisnewski AV, Jones M. Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease? Clin Exp Allergy 2010;40: 1155–1162PubMedCrossRefGoogle Scholar
  4. Limaye S, Salvi S. Ambient air pollution and the lungs: what do clinicians need to know? Breathe 2010;6: 235–244Google Scholar
  5. Schultze-Werninghaus G, Debelic M (Hrsg) Asthma – Grundlagen, Diagnostik, Therapie. Berlin: Springer Verlag, 1988, pp 177–184Google Scholar


  1. Parsons JP, Mastronarde JG. Exercise-induced asthma. Curr Opin Pulm Med 2009;15: 25–28PubMedCrossRefGoogle Scholar
  2. Schwartz LB, Delgado L, Craig T, et al. Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy). Allergy 2008;63: 953–961PubMedCrossRefGoogle Scholar
  3. Carlsen KH, Anderson SD, Bjermer L, et al; European Respiratory Society; European Academy of Allergy and Clinical Immunology. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 2008;63: 387–403PubMedCrossRefGoogle Scholar
  4. Carlsen KH, Anderson SD, Bjermer L, et al; European Respiratory Society; European Academy of Allergy and Clinical Immunology; GA[2]LEN. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA[2]LEN. Allergy 2008;63: 492–505PubMedCrossRefGoogle Scholar


  1. Harrington LS, Lucas R, McMaster SK, et al. COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma. FASEB J 2008; 22: 4005–4010PubMedCrossRefGoogle Scholar
  2. Szczeklik A, Sanak M. Genetic mechanisms in aspirin-induced asthma. Am J Respir Crit Care Med 2000;161: S142–S146PubMedGoogle Scholar

Hormone – perimenstruelles Asthma

  1. Choi IS. Gender-specific Asthma Treatment. Allergy Asthma Immunol Res 2011;3: 74–80PubMedCrossRefGoogle Scholar
  2. Salam MT, Wenten M, Gilliland FD. Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women. J Allergy Clin Immunol 2006;117: 1001–1007PubMedCrossRefGoogle Scholar
  3. Dratva J, Schindler C, Curjuric I, et al. Perimenstrual increase in bronchial hyperreactivity in premenopausal women: Results from the population-based SAPALDIA 2 cohort. J Allergy Clin Immunol 2010;125: 823–829PubMedCrossRefGoogle Scholar
  4. Martinez-Moragón E, Plaza V, Serrano J, et al. Near-fatal asthma related to menstruation. J Allergy Clin Immunol 2004;113: 242–244PubMedCrossRefGoogle Scholar
  5. Barr RG, Wentowski CC, Grodstein F, et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 2004;164: 379–386PubMedCrossRefGoogle Scholar
  6. Romieu I, Fabre A, Fournier A, et al. Postmenopausal hormone therapy and asthma onset in the E3N cohort. Thorax 2010;65: 292–297PubMedCrossRefGoogle Scholar

Virales Asthma

  1. Busse WW, Lemanske Jr RF, Gern JE. Role of viral respiratory infections in asthma and asthma exazerbations. Lancet 2010;376: 826–834PubMedCrossRefGoogle Scholar

Gastroösophagealer Reflux

  1. Dal Negro RW, Aubier M. Bronchial asthma and gastro-oesophageal reflux. Eur Respir Mon 2003;23: 260–277Google Scholar

Psychische Faktoren

  1. Schultze-Werninghaus G, Debelic M (Hrsg) Asthma – Grundlagen, Diagnostik, Therapie. Berlin: Springer Verlag, 1988, pp 190–197.Google Scholar
  2. Thomas M, Bruton A, Moffatt M, et al. Asthma and psychological dysfunction. Prim Care Respir J 2011. doi: 10.4104/pcrj.2011.00058. [Epub ahead of print]


  1. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368: 804–813PubMedCrossRefGoogle Scholar
  2. Bush A, Menzies-Gow A. Phenotypic differences between pediatric and adultaAsthma. Proc Am Thorac Soc 2009; 6: 712–719PubMedCrossRefGoogle Scholar
  3. Fitzpatrick AM, Higgins M, Holguin F, et al; WG; National Institutes of Health/National Heart, Lung, and Blood Institute's Severe Asthma Research Program. The molecular phenotype of severe asthma in children. J Allergy Clin Immunol 2010;125: 851–857PubMedCrossRefGoogle Scholar
  4. Baines KJ, Simpson JL, Wood LG, et al. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 2011;127: 153–160PubMedCrossRefGoogle Scholar
  5. Moore WC, Meyers DA, Wenzel SE, et al, for the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010;181: 315–323PubMedCrossRefGoogle Scholar
  6. Wechsler ME, Kunselman SJ, Chinchilli VM, et al; National Heart, Lung and Blood Institute's Asthma Clinical Research Network. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009;374: 1754–1764PubMedCrossRefGoogle Scholar
  7. Siroux V, Basagaña X, Boudier A, et al. Identifying adult asthma phenotypes using a clustering approach. Eur Respir J 2011;38: 310–317PubMedCrossRefGoogle Scholar


  1. Buhl R, Berdel D, Criée CP, et al. Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. Pneumologie 2006;60: 139–177PubMedCrossRefGoogle Scholar
  2. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol 2004;113: 59–65PubMedCrossRefGoogle Scholar
  3. Schatz M, Kosinski M, Yarlas AS, et al. The minimally important difference of the Asthma Control Test J Allergy Clin Immunol 2009;124: 719–723PubMedCrossRefGoogle Scholar
  4. Agnew M. Spirometry in clinical use: practical issues. Breathe 2010;6: 197–203Google Scholar
  5. Garbe B. Achieving quality spirometry in the office. Breathe 2010;6: 211–219Google Scholar
  6. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol 2008;122: 238–246PubMedCrossRefGoogle Scholar
  7. Jarisch R, Kummer F, Oppolzer R. Das Asthmaprogramm. Wien Klin Wochenschr 1975;87: 740–747PubMedGoogle Scholar
  8. Craig TJ. Aeroallergen sensitization in asthma: prevalence and correlation with severity. Allergy Asthma Proc 2010;31: 96–102PubMedCrossRefGoogle Scholar


  1. Demoly P, Gueron B, Annunziata K, et al. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010;19: 150–157PubMedCrossRefGoogle Scholar
  2. Bousquet J, Clark TJH, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy 2007;62: 102–112PubMedGoogle Scholar
  3. Barnes PJ. Corticosteroids: the drugs to beat. Eur J Pharmacol 2006;533: 2–14PubMedCrossRefGoogle Scholar
  4. Sturton G, Persson C, Barnes PJ. Small airways: an important but neglected target in the treatment of obstructive airway diseases. Trends Pharmacol Sci 2008;29: 340–345PubMedCrossRefGoogle Scholar
  5. Barnes PJ. New therapies for asthma: is there any progress? Trends Pharmacol Sci 2010;31: 335–343PubMedCrossRefGoogle Scholar
  6. Barnes PJ. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 2004;1: 264–268PubMedCrossRefGoogle Scholar
  7. LaForce C, Alexander M, Deckelmann R, et al. Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study. Allergy 2008;63: 103–111PubMedCrossRefGoogle Scholar


  1. Holgate S, Smith N, Massanari M, et al. Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy 2009;64: 1728–1736PubMedCrossRefGoogle Scholar
  2. Nopp A, Johansson SGO, Adedoyin J, et al. After 6 years with Xolair; a 3-year withdrawal follow-up Allergy 2010;65: 56–60PubMedCrossRefGoogle Scholar

Therapie der allergischen Rhinitis nach ARIA

  1. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol 2010;126: 466–476PubMedCrossRefGoogle Scholar

Spezifische Immuntherapie

  1. Kleine-Tebbe J, Bufe A, Ebner C et al. Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten Erkrankungen. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen(ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI). Allergo J 2009;18: 508–537Google Scholar
  2. Calderon MA, Casale TB, Togias A et al. Allergen-specific immunotherapy for respiratory allergies:From meta-analysis to registration and beyond. J Allergy Clin Immunol 2011;127: 30–38PubMedCrossRefGoogle Scholar
  3. Bachert C, Devuyst L. Wirksamkeit von Präparaten mit nicht modifizierten Allergenen zur subkutanen Applikation Evidenzbewertung anhand klinischer Studien. Allergologie 2010;33: 379–394Google Scholar
  4. Bachert C, Gevaert P, van Zele T. Wirksamkeit von Allergoiden zur subkutanen Applikation – Evidenzbewertung anhand klinischer Studien. Allergologie 2009;32: S83–S92Google Scholar
  5. Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010;8: CD001186PubMedGoogle Scholar
  6. Blumberga G, Groes L, Dahl R. SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma. Allergy 2011;66: 178–185PubMedCrossRefGoogle Scholar
  7. Jacobsen L, Niggemann B, Dreborg S et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62: 943–948PubMedCrossRefGoogle Scholar
  8. Massanari M, Nelson H, Casale T, et al. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. J Allergy Clin Immunol 2010;125: 383–389PubMedCrossRefGoogle Scholar

Perimenstruelles Asthma

  1. Vrieze A, Postma DS, Kerstjens HAM. Perimenstrual asthma: A syndrome without known cause or cure. J Allergy Clin Immunol 2003;112: 271–282PubMedCrossRefGoogle Scholar

Schweres Asthma

  1. Peters SP, Kunselman SJ, Icitovic N, et al; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363: 1715–1726PubMedCrossRefGoogle Scholar
  2. Reed CE. Asthma in the elderly: diagnosis and management. J Allergy Clin Immunol 2010;126: 681–687PubMedCrossRefGoogle Scholar
  3. Eden E. Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis. COPD 2010;7: 366–374PubMedCrossRefGoogle Scholar
  4. Huber F, Schmid-Scherzer K, Wantke F, et al. Alpha1-antitrypsin deficiency in Austria: analysis of the Austrian Alpha1-international-registry database. Wien Klin Wochenschr 2010;122: 390–396PubMedCrossRefGoogle Scholar
  5. Heaney LG, Robinson DS. Severe asthma treatment: need for characterising patients. Lancet 2005;365: 974–976PubMedCrossRefGoogle Scholar

Experimentelle Ansätze

  1. O'Byrne PM. The demise of anti IL-5 for asthma, or not. Am J Respir Crit Care Med 2007;176: 1059–1560PubMedCrossRefGoogle Scholar
  2. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exazerbations of refractory eosinophilic asthma. N Engl J Med 2009;360: 973–984PubMedCrossRefGoogle Scholar
  3. Deshpande DA, Wang WCH, McIlmoyle EL, et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nature Medicine 2010;16: 1209–1304CrossRefGoogle Scholar
  4. Meyerhof W, Batram C, Kuhn C, et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses 2010;35: 157–170PubMedCrossRefGoogle Scholar


  1. Haber H, Raber W, Vetter N. Bronchial asthmatic disease associated with tobacco dust--an occupational lung disease? Wien Klin Wochenschr 2004;116 (Suppl 1): 38–39PubMedGoogle Scholar
  2. Moscato G, Pala G, Boillat MA, et al. EAACI Position Paper: Prevention of work-related respiratory allergies among pre-apprentices or apprentices and young workers. Allergy 2011; 66:1164–1173PubMedCrossRefGoogle Scholar
  3. Pesek R, Lockey R. Vaccination of adults with asthma and COPD. Allergy 2011;66: 425–431CrossRefGoogle Scholar
  4. Schembri S, Morant S, Winter JH, et al. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 2009;64: 567–572PubMedCrossRefGoogle Scholar

Status asthmaticus

  1. Camargo CA Jr, Rachelefsky G, Schatz M. Managing asthma exazerbations in the emergency department: summary of the National Asthma Education And Prevention Program Expert Panel Report 3 guidelines for the management of asthma exazerbations. Proc Am Thorac Soc 2009; 6: 357–366PubMedCrossRefGoogle Scholar
  2. Soroksky A, Klinowski E, Ilgyev E, et al. Noninvasive positive pressure ventilation in acute asthmatic attack. Eur Respir Rev 2010;19: 39–45PubMedCrossRefGoogle Scholar

Schwangerschaft & Asthma

  1. Belanger K, Hellenbrand ME, Holford TR, et al. Effect of pregnancy on maternal asthma symptoms and medication use. Obstet Gynecol 2010;115: 559–567PubMedCrossRefGoogle Scholar
  2. Schatz M, Dombrowski MP. Asthma in pregnancy. N Engl J Med 2009;360: 1862–1869PubMedCrossRefGoogle Scholar
  3. Yawn B, Knudtson M. Treating asthma and comorbid allergic rhinitis in pregnancy. J Am Board Fam Med 2007; 20: 289–298PubMedCrossRefGoogle Scholar
  4. Tata LJ, Lewis SA, McKeever TM, et al. Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax 2008;63: 981–987PubMedCrossRefGoogle Scholar
  5. Blais L, Beauchesne MF, Lemiere M, et al. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol 2009;124: 1229–1234PubMedCrossRefGoogle Scholar
  6. Martel MJ, Rey E, Beauchesne MF, et al. Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study. Eur Respir J 2009;34: 579–587PubMedCrossRefGoogle Scholar

Alter & Asthma

  1. Huss K, Naumann PL, Mason PJ, et al. Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol 2001; 86: 528–534CrossRefGoogle Scholar
  2. Busse PJ. Allergic respiratory disease in the elderly. Am J Med 2007;120: 498–502PubMedCrossRefGoogle Scholar
  3. Stupka E, deShazo RD. Asthma in seniors: Part 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality. Am J Med 2009;122: 6–11PubMedCrossRefGoogle Scholar
  4. deShazo RD, Stupka JE. Asthma in US seniors: part 2. Treatment. Seeing through the glass darkly. Am J Med 2009:122: 109–113PubMedCrossRefGoogle Scholar
  5. Moorman JE, Rudd RA, Johnson CA et al; Centers for Disease Control and Prevention (CDC). (2007). National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ 2007:56: 1–54Google Scholar
  6. Busse PJ, Mathur SK. Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol 2010;126: 690–699PubMedCrossRefGoogle Scholar
  7. Church MK, Maurer M, Simons FER, et al. Risk of first-generation H1-antihistamines: a GA2LEN position paper Allergy 2010;65:459–466PubMedCrossRefGoogle Scholar
  8. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010:376: 803–813PubMedCrossRefGoogle Scholar
  9. Marcon A, Corsico A, Cazzoletti L, et al and the Therapy and Health Economics Group of the European Community Respiratory Health Survey. Body mass index, weight gain, and other determinants of lung function decline in adult asthma. J Allergy Clin Immunol 2009;123:1069–1074PubMedCrossRefGoogle Scholar

Tauchen & Asthma

  1. Tetzlaff K. Checkliste Tauchtauglichkeit. Stuttgart: Gentner Verlag, 2009Google Scholar
  2. Klingmann Ch, Tetzlaff K. Moderne Tauchmedizin. Stuttgart: Gentner Verlag, 2007Google Scholar

Berufsbedingtes Asthma bronchiale

  1. Schönberger Mehrtens V. Arbeitsunfall und Berufskrankheit. 8. Auflage. Erich Schmidt Verlag. 2010Google Scholar
  2. Hoy RF, Abramson MJ, Sim MR. Work related asthma - diagnosis and management. Aust Fam Physician 2010;39: 39–42PubMedGoogle Scholar
  3. Cowl CT. Occupational asthma: review of assessment, treatment, and compensation. Chest 2011;139: 674–681PubMedCrossRefGoogle Scholar
  4. Peden D, Reed CE. Environmental and occupational allergies. J Allergy Clin Immunol 2010;125: S150–S160PubMedCrossRefGoogle Scholar
  5. Rachiotis G, Savani R, Brant A, et al. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007;62: 147–152PubMedCrossRefGoogle Scholar
  6. Vandenplas O, Dressel H, Wilken D, et al; on behalf of the ERS Task Force on the Management of Work-related Asthma. Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J 2011 Mar 24. [Epub ahead of print]Google Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Floridsdorfer AllergieambulatoriumWienAustria

Personalised recommendations